Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses ...

Here, the authors show that targeting the more divergent allosteric binding sites, which are topographically distinct from the acetylcholine binding site, allows selective modulation of a ...